DOI: https://dx.doi.org/10.18203/2394-6040.ijcmph20222344
Published: 2022-09-28

Overview of the causes and types of recurrent cystitis

Riyadh Mohammed Alaryan, Ali Artam Alajmi, Osama Othman Alkhudhair, Abdulelah Ahmed Alabdulwahab, Eid Mohammed Alsharif, Abdullatif Ahmed Alfaifi, Wael Hassan Alanazi, Abdulrahman Ali Alamri, Ahmed Hamoud Alharthi, Abdulrahim A. Mirza, Waad Hasan Alharbi

Abstract


Bacterial cystitis accounts for the majority of urinary tract infection (UTI). It is frequently found in young, otherwise healthy females showing no signs of anatomical or physiological urinary tract defects. Among young women who have experienced an episode of acute bacterial cystitis, 25% to 50% develop recurrent episodes. Individuals with recurrent cystitis episodes have a greater susceptibility to urogenital colonization with uropathogens that thrive by adhering to uroepithelial cells. Further, there is an increased likelihood of infection with an antibiotic resistant uropathogen due to previous antimicrobial therapy for recurring infections. At each step of the pathogenesis, different host genetic, biologic, and behavioral factors, and bacterial factors interact and influence susceptibility to recurrent cystitis. Behavioral factors like sexual intercourse, use of spermicidal contraceptives and history of recurrent cystitis are major independent risk factors for recurrent cystitis infections. In post-menopausal women without comorbidities, estrogen depletion is mainly responsible for increased susceptibility to recurrent cystitis. Certain strain-specific bacterial virulence determinants may also contribute to recurrent cystitis by providing a selective advantage. Phenotypically, recurrent cystitis is categorized as reinfection or bacterial persistence. Majority of recurrent cystitis cases seen in men occur due to structural or functional abnormalities of the urinary bladder which allows same pathogens from the same site in the bladder to cause recurrences due to bacterial persistence. The concept of ‘uncomplicated’ and ‘complicated’ recurrent cystitis is used for classification of recurrent cystitis cases, similar to UTIs. Uncomplicated recurrent cystitis comprises cases occurring in young, healthy, nonpregnant women, mainly due to uropathogenic Escherichia coli. Due to the unique spectrum of host-bacterial interactions in the urinary tract, the distinction between complicated and uncomplicated recurrent cystitis is not straightforward. ‘Complicating’ factors such as structural, obstructive, neoplastic, functional, and neurological abnormalities of the urinary tract, systemic conditions including pregnancy, and certain demographic factors are attributed in the development of complicated recurrent bacterial cystitis.


Keywords


UTI, Recurrent, Cystitis, Uropathogen, Escherichia coli

Full Text:

PDF

References


Lee G, Romih R, Zupančič D. Cystitis: from urothelial cell biology to clinical applications. BioMed Res Int. 2014;2014.

Chew LD, Fihn SD. Recurrent cystitis in nonpregnant women. West J Med. 1999;170(5):274-7.

Madersbacher S, Thalhammer F, Marberger M. Pathogenesis and management of recurrent urinary tract infection in women. Curr Opin Urol. 2000;10(1):29-33.

Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Eng J Med. 1993;329(18):1328-34.

Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17(4):259-68.

Vecchio M, Iroz A, Seksek I. Prevention of cystitis: travelling between the imaginary and reality. Ann Nutri Metabol. 2018;72(2):8-10.

Droupy S. The therapeutic approach to different forms of cystitis: impact on public health. Urologia J. 2017;84(1):8-15.

Dwyer PL, O'Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynecol. 2002;14(5):537-43.

Svanborg C, Godaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin N Am. 1997;11(3):513-29.

Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991;4(1):80-128.

Murray BO, Flores C, Williams C. Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems. Front Cell Infect Microbiol. 2021;11:691210.

Justice SS, Hunstad DA, Seed PC, Hultgren SJ. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proceed National Academy Sci. 2006;103(52):19884-9.

Ho HJ, Tan MX, Chen MI. Interaction between antibiotic resistance, resistance genes, and treatment response for urinary tract infections in primary care. J Clin Microbiol. 2019;57(9):e00119-43.

Carvalho G, Forestier C, Mathias J-D. Antibiotic resilience: a necessary concept to complement antibiotic resistance? Proceed Royal Society B. 2019;286(1916):20192408.

De Vos MG, Zagorski M, McNally A, Bollenbach T. Interaction networks, ecological stability, and collective antibiotic tolerance in polymicrobial infections. Proceed National Acad Sci. 2017;114(40):10666-671.

Olsen I. Biofilm-specific antibiotic tolerance and resistance. Euro J Clin Microbiol Infect Dis. 2015;34(5):877-86.

Stapleton A. Prevention of recurrent urinary-tract infections in women. Lancet. 1999;353(9146):7-8.

Scholes D, Hawn TR, Roberts PL. Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol. 2010;184(2):564-9.

Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182(4):1177-82.

Bruyère F, Sotto A, Benoit JM. Recurrent cystitis in post-menopausal patients more or less than 65 years of age. Med Mal Infect. 2013;43(5):185-8.

Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis. 1998;178(2):446-50.

Hooton TM, Hillier S, Johnson C, Roberts PL, Stamm WE. Escherichia coli bacteriuria and contraceptive method. JAMA. 1991;265(1):64-69.

Hooton TM, Scholes D, Hughes JP. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Eng J Med. 1996;335(7):468-74.

Fihn SD, Boyko EJ, Chen C-L, Normand EH, Yarbro P, Scholes D. Use of spermicide-coated condoms and other risk factors for urinary tract infection caused by Staphylococcus saprophyticus. Arch Int Med. 1998;158(3):281-7.

Johansen TEB, Botto H, Cek M. Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents. 2011;38:64-70.

Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-40.

Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992;15(1):S216-27.

Rubin R, Shapiro E, Andriole V, Davis R, Stamm W. General guidelines for the evaluation of new anti-infective drugs for the treatment of UTI. Euro Society Clin Microbiol Infect Dis. 1993:240-310.

McKertich K, Hanegbi U. Recurrent UTIs and cystitis symptoms in women. Aust J Gen Pract. 2021;50(4):199-205.

Kolman KB. Cystitis and pyelonephritis: diagnosis, treatment, and prevention. Primary Care: Clin Office Pract. 2019;46(2):191-202.

Yoon BI, Kim SW, Ha US, Sohn DW, Cho YH. Risk factors for recurrent cystitis following acute cystitis in female patients. J Infect Chemother. 2013;19(4):727-31.

Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113(1):14-19.

Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public health. 1990;80(3):331-3.

McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mole Med. 2016;22(11):946-57.